Accelerating clinical development in Neurosciences
With over thirty years of clinical and pharmaceutical experience in the field of Neurosciences, Dr Marie Trad, M.D., President and Founder of Neuraltra, brings her in-depth knowledge and expertise to support global clinical development from early stages throughout the lifecycle of drug development. Dr Trad is a board-certified Neurologist and a qualified Neuroradiologist from the Pierre and Marie Curie University, Paris, France. After over a decade of clinical practice, Marie joined the Pharmaceutical industry in 2000 where she has occupied different senior and strategic roles both in Pharma and CRO, spanning from head of the Eu Neurology medical group to head of the CNS unit dedicated to Biotechs. During her twenty years in the pharma industry, Dr Trad has provided senior consultancy to sponsors supporting their multiple compounds’ NDAs. Her multivalent experience in clinical trial management providing medical, clinical, and global strategic support related to NPPI clinical trials, her significant experience in Neuroradiology and her strong relationship with specialized clinical trial centers, makes Dr Trad and Neuraltra, a reliable partner for your development plans.
Neuraltra partners with multiple stakeholders and experts in the Pharma industry and Academia: Regulatory, Operational, Strategic, Biostatistics and QA experts, as well as Key Opinion Leaders (KOLs), Scientific Consortia, and Patient Advocacy Groups (PAGs).
Peer to Peer
“I work on a daily basis with Dr Marie Trad. I am the main medical contact at the pharma company. This project would not be successful without the efforts and intellectual horsepower that Marie brings to the project. She understands the disease we are studying probably better than anyone on the project. She is our Key Opinion Leader, as good as any of the outside consultants we work with, as she understands completely drug development. She knows when to be rigid to maintain scientific and medical integrity and she knows when to be flexible so that the program can be completed on time – an absolutely invaluable skill set. This comes from her superb medical training and her extensive experience in drug development. I have been in drug development for 31 years and I have never worked with anyone better than Marie. I hope the CRO understands what a valuable asset she is to you and to us.” Medical program Director, Large Pharma.
“Dr. Trad is considered a primary stakeholder to the team and a key asset to our program’s near term successes from her thoughtful contributions. Dr. Trad consistently goes above and beyond to gather information both locally and globally. As an excellent communicator, she takes the time to understand each aspect of the team and the roles and responsibilities of each colleague. Knowing that Dr. Trad’s medical expertise influences patient outcomes of potentially thousands of patients, we take great reward in the fact that she plays such an integral role in the success of our programs.” Medical and Clinical Operations Leads, Mid-size pharma.